• What We Do
  • Who We Are
  • Simulations
  • Presentations & Research
  • Contact Us
  • White Paper
  • Disclaimer
  • Industry Sector
  • Global Region
  • Exchange Traded Funds
  • Major Funds - Holding
  • Tutorial
  • Best Risk Adjusted
  • Worst Risk Adjusted
  • Best Expected
  • Worst Expected
  • Sector Ranking
  • Dividend
  • REIT's
  • Leverage Risk
  • Convertible Bonds
  • Investment Grade
  • High Yield
  • ADR
  • Small Caps
Rational Investing
  • About Usarrow_drop_down
  • Coveragearrow_drop_down
  • Returnsarrow_drop_down
  • Productarrow_drop_down


Drugs - Generic

       Total Market Capitalization of All Firms 89073 mm             
       Average Market Capitalization 17815 mm       
       Average Market to Model Ratio Weighted by Log of Market Cap 1.28       
       Standard Deviation of MM Ratio 0       
       Average Beta 1.37       
       Average EV To Revenue 3.49       
       Average Price To Free Cash Flow 17.54       

TickerCompany NameMarket To ModelMarket Cap ($ mm)EV to RevenuePrice To FCF% GrowthBetaAs Of
ANIPANI Pharmaceuticals Inc2.67524.137.2142.24Dec 18
MYLMylan N.V.1.514,4662.48.121.43Dec 18
AGNAllergan PLC1.050,5644.97.5-31.26Dec 18
RDYDr Reddy Laboratories Ltd0.96,4503.429.050.14Dec 18
TEVATeva Pharmaceutical Industries0.816,8402.75.9-51.77Dec 18
Standard Value | About us | Contact us     Copyright © 2003-2019 Rational Investing LLC ® | All Rights Reserved